Discover 1,665 paid clinical trials in Colorado. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Colorado offers a variety of paid research opportunities, including paid studies for healthy volunteers and trials for those with specific health needs. Research hubs in Denver, Colorado Springs, and Boulder are actively recruiting participants, providing access to innovative treatments and exceptional medical care.
Filter
1
Filter results
Results: 1,665
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Boston MA, New Haven CT, New York NY, Montreal,
Sponsor: Servier Bio-Innovation LLC
Sex: All
Age: 18+
Code: NCT06127407
Phase3, Recruiting
Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
Location: Staten Island NY, Boulder CO, Santa Monica CA,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 2 - 65
Code: NCT05361707
Phase3, Recruiting
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
for
Pancreatic Cancer
Location: Lake Success NY, Millburn NJ, Montreal, Baltimore MD,
Sponsor: University of Louisville
Sex: All
Age: 18+
Code: NCT02674100
Recruiting
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: North Haven CT, Ottawa, Toronto, Orlando FL,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06384352
Phase1, Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Hartford CT, Sherbrooke, New York NY, Montreal,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase3, Recruiting
ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)
for
Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Location: Boston MA, Philadelphia PA, Baltimore MD, Nashville TN,
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: Male
Age: 2 - 65
Code: NCT06430385
Phase1, Phase2, Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Boston MA, Burlington MA, Norfolk MA, Hartford CT,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06433752
Recruiting
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
for
Advanced Solid Tumor,
Location: Boston MA, Lebanon NH, Morristown NJ,
Sponsor: Vaxiion Therapeutics
Sex: All
Age: 18+
Code: NCT05901285
Phase1, Recruiting
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
for
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8,
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
for
Heart Failure and Impaired Kidney Function
Location: Sydney, Boston MA, Providence RI, Worcester MA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06307652
Phase3, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Portland ME, Scarborough ME, Boston MA, Providence RI,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
for
Metastatic Solid Tumor, Advanced Solid Tumor,
Location: Boston MA, New York NY, Fairfax VA, Miami FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06561685
Phase1, Recruiting
CtDNA Based MRD Testing for NAC Monitoring in TNBC
for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: Stony Brook NY, York PA, Washington DC DC,
Sponsor: Personalis Inc.
Sex: Female
Age: 18+
Code: NCT06230185
Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors
for
Solid Tumor
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT05382559
Phase1, Recruiting
Interstitial Lung Disease in Early Rheumatoid Arthritis
for
Rheumatoid Arthritis, Interstitial Lung Disease
Location: Denver CO
Sponsor: National Jewish Health
Sex: All
Age: 18 - 70+
Code: NCT03977415
Recruiting
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
for
KRAS G12C Mutation, KRAS G12S Mutation,
Location: Boston MA, Philadelphia PA, Fairfax VA, Jacksonville FL,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT06720987
Phase1, Recruiting
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition